Actinium Pharmaceuticals, Inc. — All Filings
491 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10SB12G
3
3/A
4
424B3
424B5
8-A12B
8-K
8-K/A
ARS
CERTNYS
CORRESP
D
D/A
DEF 14A
DEF 14C
DEFA14A
EFFECT
NT 10-K
NT 10-Q
PRE 14A
PRE 14C
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K/A | AMENDMENT NO.1 TO FORM 8-K | 0001213900-26-034807 | Mar 26, 2026 | Nov 26, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-016559 | Feb 13, 2026 | Feb 11, 2026 |
| 8-K | CURRENT REPORT | 0001213900-25-115586 | Nov 26, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-110979 | Nov 14, 2025 | Sep 30, 2025 |
| ARS | ARS | 0001213900-25-106708 | Nov 5, 2025 | Dec 31, 2024 |
| DEF 14A | PROXY STATEMENT | 0001213900-25-106706 | Nov 5, 2025 | Nov 26, 2025 |
| 4 | — | 0001213900-25-079019 | Aug 20, 2025 | Aug 18, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-073743 | Aug 8, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0000932471-25-000841 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002468 | Jul 16, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-041614 | May 9, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-041582 | May 9, 2025 | May 8, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028232 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028231 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028230 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028228 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028227 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028226 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-028225 | Apr 2, 2025 | Mar 31, 2025 |
| 10-K | ANNUAL REPORT | 0001213900-25-026371 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-103498 | Nov 27, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098534 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0000932471-24-000829 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000921895-24-002532 | Nov 8, 2024 | — |
| ARS | FORM ARS | 0001213900-24-094762 | Nov 6, 2024 | Dec 31, 2023 |
| 4 | — | 0001213900-24-094632 | Nov 5, 2024 | Nov 1, 2024 |
| 3 | — | 0001213900-24-094630 | Nov 5, 2024 | Nov 1, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-094622 | Nov 5, 2024 | Nov 1, 2024 |
| DEF 14A | PROXY STATEMENT | 0001213900-24-094619 | Nov 5, 2024 | Nov 27, 2024 |
| SC 13G | — | 0000932471-24-000238 | Nov 4, 2024 | — |
| SC 13G/A | — | 0000932471-24-000275 | Nov 4, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-065239 | Aug 5, 2024 | Jun 30, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-064993 | Aug 5, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-036699 | Apr 26, 2024 | Mar 31, 2024 |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-028040 | Mar 29, 2024 | — |
| 10-K | ANNUAL REPORT | 0001213900-24-028038 | Mar 29, 2024 | Dec 31, 2023 |
| SC 13G/A | — | 0000921895-24-000320 | Feb 9, 2024 | — |
| EFFECT | — | 9999999995-24-000312 | Feb 5, 2024 | — |
| S-3/A | PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | 0001213900-24-009717 | Feb 2, 2024 | — |
| CORRESP | — | 0001213900-24-009720 | Feb 2, 2024 | — |
| SC 13G | — | 0001086364-24-005168 | Jan 29, 2024 | — |
| 4 | — | 0001213900-23-100091 | Dec 29, 2023 | Dec 28, 2023 |
| 4 | — | 0001213900-23-100086 | Dec 29, 2023 | Dec 28, 2023 |
| 4 | — | 0001213900-23-100077 | Dec 29, 2023 | Dec 28, 2023 |
| 4 | — | 0001213900-23-100068 | Dec 29, 2023 | Dec 28, 2023 |
| 4 | — | 0001213900-23-100063 | Dec 29, 2023 | Dec 28, 2023 |
| 4 | — | 0001213900-23-100057 | Dec 29, 2023 | Dec 28, 2023 |
| 8-K | CURRENT REPORT | 0001213900-23-092089 | Dec 1, 2023 | Nov 30, 2023 |
| ARS | FORM ARS | 0001213900-23-085309 | Nov 9, 2023 | Dec 31, 2022 |
| DEF 14A | PROXY STATEMENT | 0001213900-23-085303 | Nov 9, 2023 | Nov 30, 2023 |